NVO — NOVO NORDISK A S catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for NOVO NORDISK A S (ticker NVO). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-21 — A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People Wit · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-08-21 in 2mo ESTIMATED	READOUT A Research Study to Investigate the Effects of CagriSema Compared to Placebo in Phase 2 · Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathy	NVO NOVO NORDISK A S	CagriSema (Cagrilintide B and Semaglutid	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-09-01 in 2mo ESTIMATED	READOUT A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Phase 2 · Chronic Kidney Disease	NVO NOVO NORDISK A S	NNC0519-0130, Semaglutide	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-10-01 in 3mo ESTIMATED	READOUT A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Part Phase 3 · Heart Failure, Systemic Inflammation	NVO NOVO NORDISK A S	Ziltivekimab	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change